Epalrestat-impurities | Pharmaffiliates

epalrestat

Epalrestat is a carboxylic acid derivative and a noncompetitive and reversible aldose reductase inhibitor used for the treatment of diabetic neuropathy, which is one of the most common long-term complications in patients with diabetes mellitus. Reference standards of Epalrestat API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Epalrestat (JP 0069)
    [catalogue_number] => PA JP0069
    [category_ids] => ,152,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => epalrestat-jp-0069-pajp0069
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

Epalrestat (JP 0069)


  • Catalogue No.:PA JP0069

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA